{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:35:52Z","timestamp":1791156952976,"version":"4.1.0"},"reference-count":38,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,12,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The recent recognition of genetic defects in telomeres and telomere repair in multiple human diseases has practical implications for hematologists and oncologists and their patients; consequences for future clinical research in hematology and other subspecialties; and even importance in the interpretation of animal experiments involving cell propagation. Telomere diseases include constitutional marrow failure as dyskeratosis congenita, some apparently acquired aplastic anemia, myelodysplasia and acute myeloid leukemia; pulmonary fibrosis; and hepatic nodular regenerative hyperplasia and cirrhosis. Accelerated telomere attrition is a likely pathophysiology of cancer arising from chronic inflammation. Telomerase can be modulated by sex hormones, which may explain the activity of androgens in marrow failure. Measurement of telomere length of peripheral blood leukocytes is a simple screening clinical assay. Detection of a mutation in a patient has implications for therapy, prognosis, monitoring, and genetic counseling. For research in hematology and oncology, telomere biology could be assessed as a risk for secondary malignancies and in graft-versus-host disease, for progression in a variety of blood cancers, and as potentially modifiable by hormone replacement strategies.<\/jats:p>","DOI":"10.1182\/asheducation-2010.1.30","type":"journal-article","created":{"date-parts":[[2011,1,16]],"date-time":"2011-01-16T14:08:48Z","timestamp":1295186928000},"page":"30-35","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":56,"title":["Telomere Biology and Telomere Diseases: Implications for Practice and Research"],"prefix":"10.1182","volume":"2010","author":[{"given":"Neal S.","family":"Young","sequence":"first","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111708332929700_B1","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMra0903373","article-title":"Telomere diseases","volume":"361","author":"Calado","year":"2009","journal-title":"N Engl J Med"},{"key":"2019111708332929700_B2","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood-2008-09-178871","article-title":"Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells","volume":"114","author":"Calado","year":"2009","journal-title":"Blood"},{"key":"2019111708332929700_B3","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1349-7006.2008.00878.x","article-title":"Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers","volume":"99","author":"Kyo","year":"2008","journal-title":"Cancer Sci"},{"key":"2019111708332929700_B4","doi-asserted-by":"crossref","first-page":"9857","DOI":"10.1073\/pnas.91.21.9857","article-title":"Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age","volume":"91","author":"Vaziri","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111708332929700_B5","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1182\/blood.V91.10.3582","article-title":"Progressive telomere shortening in aplastic anemia","volume":"91","author":"Ball","year":"1998","journal-title":"Blood"},{"key":"2019111708332929700_B6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V97.4.895","article-title":"Telomere length in leukocyte subpopulations of patients with aplastic anemia","volume":"97","author":"Brummendorf","year":"2001","journal-title":"Blood"},{"key":"2019111708332929700_B7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng0598-32","article-title":"X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions","volume":"19","author":"Heiss","year":"1998","journal-title":"Nat Genet"},{"key":"2019111708332929700_B8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/990141","article-title":"A telomerase component is defective in the human disease dyskeratosis congenita","volume":"402","author":"Mitchell","year":"1999","journal-title":"Nature"},{"key":"2019111708332929700_B9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/35096585","article-title":"The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita","volume":"413","author":"Vulliamy","year":"2001","journal-title":"Nature"},{"key":"2019111708332929700_B10","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/hmg\/ddm111","article-title":"Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10","volume":"16","author":"Walne","year":"2007","journal-title":"Hum Mol Genet"},{"key":"2019111708332929700_B11","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1073\/pnas.0800042105","article-title":"Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita","volume":"105","author":"Vulliamy","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111708332929700_B12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ajhg.2007.10.004","article-title":"TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita","volume":"82","author":"Savage","year":"2008","journal-title":"Am J Hum Genet"},{"key":"2019111708332929700_B13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","article-title":"Dyskeratosis congenita in all its forms","volume":"110","author":"Dokal","year":"2000","journal-title":"Br J Haematol"},{"key":"2019111708332929700_B14","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa042980","article-title":"Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia","volume":"352","author":"Yamaguchi","year":"2005","journal-title":"N Engl J Med"},{"key":"2019111708332929700_B15","first-page":"699","article-title":"Telomeres in T and B cells","volume":"2","author":"Hodes","year":"2002","journal-title":"Nat New Biol"},{"key":"2019111708332929700_B16","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0140-6736(03)14797-6","article-title":"Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA","volume":"362","author":"Fogarty","year":"2003","journal-title":"Lancet"},{"key":"2019111708332929700_B17","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0701009104","article-title":"Adult-onset pulmonary fibrosis caused by mutations in telomerase","volume":"104","author":"Tsakiri","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111708332929700_B18","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa066157","article-title":"Telomerase mutations in families with idiopathic pulmonary fibrosis","volume":"356","author":"Armanios","year":"2007","journal-title":"N Engl J Med"},{"key":"2019111708332929700_B19","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/jmg.2008.057356","article-title":"A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis","volume":"45","author":"Mushiroda","year":"2008","journal-title":"J Med Genet"},{"key":"2019111708332929700_B20","doi-asserted-by":"crossref","first-page":"15960","DOI":"10.1073\/pnas.0508124102","article-title":"Haplon sufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita","volume":"102","author":"Armanios","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111708332929700_B21","doi-asserted-by":"crossref","first-page":"e7926","DOI":"10.1371\/journal.pone.0007926","article-title":"A spectrum of severe familial liver disorders associate with telomerase mutations","volume":"4","author":"Calado","year":"2009","journal-title":"PloS One"},{"key":"2019111708332929700_B22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1101\/sqb.2005.70.032","article-title":"Telomere-related genome instability in cancer","volume":"70","author":"de Lange","year":"2005","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"2019111708332929700_B23","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/nm1006-1133","article-title":"Telomeres and telomerase: the path from maize, tetrahymena and yeast to human cancer and aging","volume":"12","author":"Blackburn","year":"2006","journal-title":"Nat Med"},{"key":"2019111708332929700_B24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0092-8674(01)00457-3","article-title":"Telomere dysfunction increases mutation rate and genomic instability","volume":"106","author":"Hackett","year":"2001","journal-title":"Cell"},{"key":"2019111708332929700_B25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/35020592","article-title":"Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice","volume":"406","author":"Artandi","year":"2000","journal-title":"Nature"},{"key":"2019111708332929700_B26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ng989","article-title":"Chromosomal instability in ulcerative colitis is related to telomere shortening","volume":"32","author":"O'Sullivan","year":"2002","journal-title":"Nat Genet"},{"key":"2019111708332929700_B27","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1158\/1055-9965.EPI-07-0624","article-title":"Leukocyte telomere length predicts cancer risk in Barrett's esophagus","volume":"16","author":"Risques","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019111708332929700_B28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood-2009-03-209833","article-title":"Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sex","volume":"114","author":"Baerlocher","year":"2009","journal-title":"Blood"},{"key":"2019111708332929700_B29","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1182\/blood-2008-12-192880","article-title":"Cancer in dyskeratosis congenita","volume":"113","author":"Alter","year":"2009","journal-title":"Blood"},{"key":"2019111708332929700_B30","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2010.1376","article-title":"Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia","volume":"304","author":"Scheinberg","year":"2010","journal-title":"JAMA"},{"key":"2019111708332929700_B31","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1073\/pnas.0807057106","article-title":"Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia","volume":"106","author":"Calado","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111708332929700_B32","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/humu.21115","article-title":"Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia","volume":"30","author":"Vulliamy","year":"2009","journal-title":"Hum Mutat"},{"key":"2019111708332929700_B33","first-page":"3557","article-title":"Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes","volume":"54","author":"Ohyashiki","year":"1994","journal-title":"Cancer Res"},{"key":"2019111708332929700_B34","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.leukres.2003.11.020","article-title":"Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?","volume":"28","author":"Sieglova","year":"2004","journal-title":"Leuk Res"},{"key":"2019111708332929700_B35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.leu.2400889","article-title":"Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy","volume":"12","author":"Engelhardt","year":"1998","journal-title":"Leukemia"},{"key":"2019111708332929700_B36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.2008.17.1033","article-title":"Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma","volume":"27","author":"Chakraborty","year":"2009","journal-title":"J Clin Oncol"},{"key":"2019111708332929700_B37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20286","article-title":"Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes","volume":"45","author":"Swiggers","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"2019111708332929700_B38","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2007-02-075598","article-title":"Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita","volume":"110","author":"Alter","year":"2007","journal-title":"Blood"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2010\/1\/30\/1493171\/bep00110000030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2010\/1\/30\/1493171\/bep00110000030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T08:33:43Z","timestamp":1573979623000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2010\/1\/30\/95879\/Telomere-Biology-and-Telomere-Diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,4]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12,4]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2010.1.30","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,4]]}}}